Katherine E. Fleming-Dutra
Impact in
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Antibiotic Use and Resistance 51
-
- SARS-CoV-2 and COVID-19 Research 35
- Co-authors
- Lauri A. Hicks (38 shared papers)Rebecca M. Roberts (6 shared papers)Adam L. Hersh (23 shared papers)Guillermo V. Sanchez (4 shared papers)Amadea Britton (12 shared papers)Laura King (17 shared papers)Tamara Pilishvili (6 shared papers)Zachary Smith (9 shared papers)
- Journals
- MMWR Morbidity and Mortality Weekly Report (25 papers)Open Forum Infectious Diseases (13 papers)The Pediatric Infectious Disease Journal (12 papers)Clinical Infectious Diseases (11 papers)PEDIATRICS (9 papers)
- Partner nations
- United StatesUnited KingdomKenya
In The Last Decade
Katherine E. Fleming-Dutra
130 papers receiving 7.7k citations
Katherine E. Fleming-Dutra's Hit Papers
Peers
Comparison fields: 5 of 145
- Applied Microbiology and Biotechnology 2.5k
- Infectious Diseases 2.4k
- Modeling and Simulation 326
- Epidemiology 1.5k
- Health 374
Countries citing papers authored by Katherine E. Fleming-Dutra
This map shows the geographic impact of Katherine E. Fleming-Dutra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Fleming-Dutra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Fleming-Dutra more than expected).
Fields of papers citing papers by Katherine E. Fleming-Dutra
This network shows the impact of papers produced by Katherine E. Fleming-Dutra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Fleming-Dutra. The network helps show where Katherine E. Fleming-Dutra may publish in the future.
Co-authors
The 25 scholars most cited alongside Katherine E. Fleming-Dutra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011 Hit paper breakdown → | 2016 | 1380 |
| 2 | Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 Hit paper breakdown → | 2020 | 1104 |
| 3 | Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants Hit paper breakdown → | 2022 | 512 |
| 4 | Core Elements of Outpatient Antibiotic Stewardship Hit paper breakdown → | 2016 | 489 |
| 5 | Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Hit paper breakdown → | 2023 | 251 |
| 6 | Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus–Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 Hit paper breakdown → | 2023 | 218 |
| 7 | 2021 | 153 | |
| 8 | 2018 | 142 | |
| 9 | 2019 | 127 | |
| 10 | 2022 | 122 | |
| 11 | 2022 | 114 | |
| 12 | 2022 | 112 | |
| 13 | Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024 Hit paper breakdown → | 2024 | 110 |
| 14 | Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023 Hit paper breakdown → | 2023 | 108 |
| 15 | Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Hit paper breakdown → | 2024 | 108 |
| 16 | 2018 | 105 | |
| 17 | 2020 | 105 | |
| 18 | Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023 Hit paper breakdown → | 2023 | 101 |
| 19 | 2013 | 96 | |
| 20 | 2013 | 89 |
About Katherine E. Fleming-Dutra
Katherine E. Fleming-Dutra is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Epidemiology, Health and Modeling and Simulation, having authored 130 papers that have together received 8.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (51 papers), SARS-CoV-2 and COVID-19 Research (35 papers), Pneumonia and Respiratory Infections (13 papers), Respiratory viral infections research (9 papers), Streptococcal Infections and Treatments (5 papers), Vaccine Coverage and Hesitancy (5 papers), Mosquito-borne diseases and control (4 papers) and COVID-19 epidemiological studies (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.5k citations), Infectious Diseases (2.4k citations), Modeling and Simulation (326 citations), Epidemiology (1.5k citations) and Health (374 citations). Katherine E. Fleming-Dutra has collaborated with scholars based in United States, United Kingdom and Kenya. Frequent co-authors include Lauri A. Hicks, Rebecca M. Roberts, Adam L. Hersh, Guillermo V. Sanchez, Amadea Britton, Laura King, Tamara Pilishvili, Zachary Smith, Emma K. Accorsi and Gordana Derado. Their work appears in journals such as MMWR Morbidity and Mortality Weekly Report, Open Forum Infectious Diseases, The Pediatric Infectious Disease Journal, Clinical Infectious Diseases and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.